Clearside Biomedical

CLSD53

Penny Stock

$1.28arrow_drop_down1.53%-$0.02

Penny Stock

CLSD53

$1.28

arrow_drop_down1.53%-$0.02

Penny Stock

Performance History

There's no data available for key stats

There's no data available for ratios/profitability stats

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Clearside Biomedical (CLSD)

Clearside Biomedical Inc (CLSD) is a pharmaceutical company that specializes in developing innovative therapies for the treatment of eye diseases. With a focus on delivering drugs to the back of the eye, Clearside Biomedical aims to provide effective and convenient treatment options for patients suffering from conditions such as macular edema, uveitis, and retinal vein occlusion.

The history of Clearside Biomedical Inc can be traced back to its founding in 2011. Since then, the company has made significant advancements in the field of ophthalmology, leveraging its proprietary SCS Microinjector technology to enable precise and targeted drug delivery. This technology allows for the administration of therapeutic agents to the suprachoroidal space, which is an attractive alternative to invasive intraocular injections.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
Headquarters: Alpharetta
Employees: 36
Exchange: NASDAQ

Keep an eye on Clearside Biomedical

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Clearside Biomedical 's (CLSD) price per share?

The current price per share for Clearside Biomedical (CLSD) is $1.28. The stock has seen a price change of -$0.02 recently, indicating a -1.54% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Clearside Biomedical (CLSD)?

For Clearside Biomedical (CLSD), the 52-week high is $2.12, which is 65.62% from the current price. The 52-week low is $0.65, the current price is 96.92% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Clearside Biomedical (CLSD) a growth stock?

Clearside Biomedical (CLSD) has shown an average price growth of 0.41% over the past three years. It has received a score of 28 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Clearside Biomedical as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Clearside Biomedical (CLSD) stock price performance year to date (YTD)?

As of the latest data, Clearside Biomedical (CLSD) has a year-to-date price change of -0.78%. Over the past month, the stock has experienced a price change of 25.49%. Over the last three months, the change has been 11.3%. Over the past six months, the figure is -21.47%. Looking at a longer horizon, the five-year price change stands at 72.48%.

help

Is Clearside Biomedical (CLSD) a profitable company?

Clearside Biomedical (CLSD) has a net income of -$32.48M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 94.87% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -8.43K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $8.23M, although specific revenue growth data is currently not available. The gross profit is $7.8M. Operating income is noted at -$24.84M. Furthermore, the EBITDA is -$25.66M.

help

What is the market capitalization of Clearside Biomedical (CLSD)?

Clearside Biomedical (CLSD) has a market capitalization of $97.17M. The average daily trading volume is 436.64K, indicating the stock's liquidity and investor engagement.

News

SUPRACHOROIDAL DRUG DELIVERY

NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

WET AMD

CLINICAL PROGRAMS

7/22/2024

Clearside Biomedical Opens Registration for Suprachoroidal - GlobeNewswire

Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery

CALENDAR OF EVENTS

PRODUCT / SERVICES ANNOUNCEMENT

MANAGEMENT STATEMENTS

6/27/2024

Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery

Why Is Clearside Biomedical Stock Gaining Today?

Why Is Clearside Biomedical Stock Gaining Today?

Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting

CLINICAL STUDY

6/12/2024

Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting

Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®

HEALTH

OTHER NEWS

PRODUCT / SERVICES ANNOUNCEMENT

5/21/2024

Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®

5/9/2024

Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates

Performance History

Score Breakdown

Welcome to Stocklytics

Analyst Forecast

Analyst Ratings

About Clearside Biomedical (CLSD)

Keep an eye on Clearside Biomedical

Frequently Asked Questions

What is Clearside Biomedical 's (CLSD) price per share?

What is the 52-week high and low for Clearside Biomedical (CLSD)?

Is Clearside Biomedical (CLSD) a growth stock?

What is Clearside Biomedical (CLSD) stock price performance year to date (YTD)?

Is Clearside Biomedical (CLSD) a profitable company?

What is the market capitalization of Clearside Biomedical (CLSD)?

News

Sign up for our newsletter

Take Your Investments to a Whole New Level